79311713 - SMART CELLS FOR LIFE

Information

• Trademark
• 79311713

• Source

• Serial Number

  79311713

• Registration Number

  6784096

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 04, 2021
  3 years ago

• Registration Date

  July 12, 2022
  2 years ago

• Transaction Date

  December 31, 2023
  10 months ago

• Status Date

  July 12, 2022
  2 years ago

• Published for Opposition Date

  April 26, 2022
  2 years ago

• Location Date

  July 12, 2022
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  AGREDA, SAMANTHA LEIGH

• Attorney Docket Number

  EBLM068.002I

  Attorney Name

  Stacey Halpern

  Law Office Assigned Location Code

  N50

• Owners

  • Tigen Pharma SA

Case File Statements

• GS0051: Pharmaceutical products and medical preparations, namely, gene-modified and non-gene-modified cellular therapies for the treatment of localized and systemic malignant hematological and oncological diseases, genetic diseases, autoimmune diseases and infectious diseases; none of the foregoing being dietary and nutritional supplement or skin care products
• GS0011: Chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in industry and science; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in the development being the manufacture, and manufacture of reagents for industrial or scientific use; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides or proteins, for use of laboratories, diagnostics and analyses for industrial or scientific use; chemical, biochemical, biological and biotechnological substances, namely, polypeptides and proteins, for use in the manufacture of pharmaceuticals; none of the foregoing being silicon and semiconductor materials or chemical compounds in the nature of Gallium arsenide, Indium phosphide, Indium gallium arsenide, Indium gallium arsenide phosphide, for the production of enzyme substrates in the field of microelectronics and none of the foregoing being dietary and nutritional supplement or skin care products
• GS0441: Medical services; pharmacy advice services, namely, pharmaceutical consultation; medical clinic services provided by medical laboratories for diagnostic purposes; preparation and dispensing of medication; preparation of prescriptions by pharmacists; none of the foregoing being dietary and nutritional supplement or skin care products
• GS0101: Medical instruments, equipment and apparatus, namely, instruments, equipment and apparatus for cell and cell material collection, thawing, washing, selection, expansion, modification, harvesting, final formulation, freezing, storage and infusion into a patient in the fields of genetic diseases, autoimmune diseases, infectious diseases, localized and systemic malignant hematological and oncological diseases and other cell and cell-material based diseases and conditions; none of the foregoing being dietary and nutritional supplement or skin care products
• GS0421: Scientific research, technological development of new products for third parties; medical research; scientific and industrial research in biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific services, namely, development of medicines, active substances and vaccines; design and development of computer hardware and software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; upgrading, maintenance and rental of computer software; updating, maintenance and rental of computer software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; software as a service (SaaS) services featuring software for controlling end-to-end process development, manufacturing, quality, and supply chain steps and featuring artificial intelligence search engine software to be used in medical and scientific research and in the development of new products in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; chemical and biological laboratory services; none of the foregoing being dietary and nutritional supplement or skin care products

Case File Event Statements

• 12/31/2023 - 10 months ago

  31 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 11/14/2022 - a year ago

  30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 10/21/2022 - 2 years ago

  29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 10/21/2022 - 2 years ago

  28 - FINAL DISPOSITION PROCESSED Type: FIMP

• 10/12/2022 - 2 years ago

  27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 7/12/2022 - 2 years ago

  26 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 7/12/2022 - 2 years ago

  25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/3/2022 - 2 years ago

  24 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 4/26/2022 - 2 years ago

  23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/26/2022 - 2 years ago

  22 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/13/2022 - 2 years ago

  21 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 4/13/2022 - 2 years ago

  20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 4/6/2022 - 2 years ago

  19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/24/2022 - 2 years ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/24/2022 - 2 years ago

  17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/24/2022 - 2 years ago

  16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/24/2022 - 2 years ago

  15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/24/2022 - 2 years ago

  14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 2/15/2022 - 2 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/14/2022 - 2 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/14/2022 - 2 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/4/2021 - 3 years ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 9/14/2021 - 3 years ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 9/14/2021 - 3 years ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 9/14/2021 - 3 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 9/13/2021 - 3 years ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/27/2021 - 3 years ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 8/27/2021 - 3 years ago

  4 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 6/5/2021 - 3 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 6/1/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/27/2021 - 3 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR